A bill to direct the Administrator of the Centers for Medicare & Medicaid Services to clarify that implanted active middle ear hearing devices are prosthetics and are not subject to the hearing aid coverage exclusion under the Medicare program.

Bill 118 s 4829, also known as the "Implanted Active Middle Ear Hearing Devices Prosthetics Clarification Act," aims to address a specific issue related to Medicare coverage for hearing devices. The bill directs the Administrator of the Centers for Medicare & Medicaid Services to clarify that implanted active middle ear hearing devices are considered prosthetics and should not be subject to the hearing aid coverage exclusion under the Medicare program.

Currently, Medicare does not cover hearing aids, which can be a significant barrier for individuals with hearing loss who rely on these devices to communicate effectively. However, implanted active middle ear hearing devices are different from traditional hearing aids as they are surgically implanted and provide more advanced technology to improve hearing.

By classifying these devices as prosthetics, the bill seeks to ensure that Medicare beneficiaries have access to the necessary hearing technology without facing financial burdens. This clarification would help individuals with hearing loss receive the care they need to maintain their quality of life and independence. Overall, Bill 118 s 4829 aims to improve access to essential hearing technology for Medicare beneficiaries by ensuring that implanted active middle ear hearing devices are recognized as prosthetics and not subject to the hearing aid coverage exclusion.